2022
DOI: 10.4240/wjgs.v14.i3.260
|View full text |Cite
|
Sign up to set email alerts
|

Successful treatment with laparoscopic surgery and sequential multikinase inhibitor therapy for hepatocellular carcinoma: A case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 26 publications
0
3
0
Order By: Relevance
“…Conversion hepatectomy is one of the essential options for prolonging survival in patients with initially unresectable HCC that has been down-staged to being resectable by conversion therapy (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44). The number of articles on the advantages of conversion surgery after molecular therapy has increased.…”
Section: Abstract It Has Been Reported That Patients With Macroscopic...mentioning
confidence: 99%
See 2 more Smart Citations
“…Conversion hepatectomy is one of the essential options for prolonging survival in patients with initially unresectable HCC that has been down-staged to being resectable by conversion therapy (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44). The number of articles on the advantages of conversion surgery after molecular therapy has increased.…”
Section: Abstract It Has Been Reported That Patients With Macroscopic...mentioning
confidence: 99%
“…After the initiation of molecular therapy, the number of patients with complete response (CR) by response evaluation criteria in solid tumors (RECIST) and modified RECIST (mRECIST) criteria in diagnostic imaging increased; in contrast, complete remission of HCC is rarely achieved by molecular therapy alone (36). Conversely, many long-term survivors, including those completely cured, have been reported in patients with initially unresectable HCC after molecular therapy followed by conversion surgery (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42)(43). Partial response (PR) or stable disease after molecular therapy is required for patients to undergo conversion surgery, but CR is not always required (31).…”
Section: Conversion Hepatectomy For Hcc With MVI After Molecular Therapymentioning
confidence: 99%
See 1 more Smart Citation